IAG . Bankinter Fija su Precio Objetivo en 3,50€ Por Acción . En Marcha la Recompra de Acciones .
08 mayo 2019
Pharma Mar (PHMMF) Raised to “Hold” at Zacks Investment Research .
PharmaMar (OTCMKTS:PHMMF) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued on Wednesday, Zacks.com reports.
Entrada más reciente
Entrada antigua
Inicio
